Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.

NCT02107885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Pharmacokinetics

Interventions

DRUG: DS-1971
DRUG: placebo

Sponsor

Daiichi Sankyo